Omnicell Inc: (NASD: OMCL)

$18.25

0.05 (0.28%)

Volume 112,353

May 23 02:57 PM ET

Zacks Rank: 2-Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		17.52 - 18.27
	
		52wk Low - High
		12.33 - 20.00
	
		Previous Close
		18.20
	
		Avg. Volume
		158,800
	
		Industry
		MEDICAL INFO SYSTEMS
	
		Market Cap
		620.60 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.05
	
		PE (Forward)
		21.67
	
		Current Year Est.
		0.84
	
		Quarterly Earnings ESP 
		NA
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		2
Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		199 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/22/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            21.67
                        
                            PEG Ratio
                            1.30
                        
                            Current Year Est.
                            0.84
                        
                            Current Quarter Estimate
                            0.21
                        
                            Most Accurate Estimate
                            NA
                        
                            Earnings ESP 
                            NA
                        
                            Next Earnings Report Date
                            08-07-2013
                        
                            EPS Last Year
                            0.61
                        
                            Expected Earnings Growth
                            16.67%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Omnicell Inc., provides clinical infrastructure and workflow automation solutions that enable healthcare facilities to acquire, manage, dispense, and deliver medications and supplies more effectively and efficiently.   
Full OMCL Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
OMCL Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.21	0.24	0.84	NA
Number of Estimates	1	1	1	0
Low Estimate	0.21	0.24	0.84	NA
High Estimate	0.21	0.24	0.84	NA
Year Ago EPS	0.13	0.22	0.60	0.84
EPS Growth	61.54%	9.09%	40.00%	NA

More OMCL Estimates

Average Earnings Estimates for OMCL

EPS Growth for OMCL

Industry Analysis

Name	Symbol	Previous Close
OMNICELL INC	OMCL	18.20
CAREVIEW COMMUN	CRVW	0.69
MERGE HEALTHCAR	MRGE	3.26
ATHENAHEALTH IN	ATHN	85.21
CERNER CORP	CERN	96.25
COMPUTER PRGRMS	CPSI	51.42
MEDIDATA SOLUTN	MDSO	67.33
QUALITY SYS	QSII	18.82
STREAMLINE HLTH	STRM	6.65
VIRTUALSCOPICS	VSCP	0.59

Sector:Medical>> Industry:MEDICAL INFO SYSTEMS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Covance Beats Earnings, Rev, Ups View

May 06, 2013

Dismal Earnings Miss by Omnicell

May 03, 2013

Still Neutral on Omnicell

Mar 22, 2013

Omnicell Beats with Record Numbers

Feb 01, 2013

The Zacks Analyst Blog Highlights: Royal Dutch Shell, Kinder Morgan, El Paso Pipeline Partners, Total SA and Omnicell

Jan 30, 2013

Omnicell Gains Foothold in Qatar

Jan 29, 2013

Omnicell in Arab Health Conference

Jan 28, 2013

Omnicell Widens Customer Base

Jan 16, 2013

More OMCL Zacks Commentary

Financials

EPS TTM	0.61
Sales	314
Net Income	17
Price/Earnings	29.84
Price/Book	1.93
Price/Cash Flow	17.80
Price/Sales	1.84

More OMCL Financials

News

Shares of Omnicell Under Pressure, Down 1.8% - Financial News Network Online - Market Movers

May 23, 2013

Highest Forward Earnings Yield in the Health Care Technology Industry Detected for MedAssets (MDAS, QSII, OMCL) - Financial News Network Online - News Corner

May 21, 2013

Omnicell Earnings Review: 18 Days after Announcement Shares Up 5.3% (OMCL) - Comtex Smartrend(R)

May 20, 2013

Omnicell Earnings In Retrospect: Up 5.3% in the Last 16 Days (OMCL) - Financial News Network Online - Earnings Lookback

May 18, 2013

Arrhythmia Research Technology Ranks the Lowest in Terms of Price to Book Ratio in the Health Care Technology Industry (HRT, MDRX, OMCL) - Financial News Network Online - News Corner

May 16, 2013

Omnicell Q1 net income increases - Datamonitor

May 16, 2013

Shares of Omnicell Receive a Boost, Up 1.6% - Financial News Network Online - Market Movers

May 15, 2013

Omnicell To Present At The 14th Annual B. Riley & Co. Investor Conference - Pr Newswire

May 14, 2013

See All News Stories on OMCL

Broker Recommendations

Current ABR	1.67
ABR (Last Week)	1.67
# of recs in ABR	6
Average Target Price	21.50
Industry Rank by ABR	199 out of 265
Rank in Industry	1 out of 13

More OMCL Broker Recommendations

Day Low - High	17.52 - 18.27
52wk Low - High	12.33 - 20.00
Previous Close	18.20
Avg. Volume	158,800
Industry	MEDICAL INFO SYSTEMS
Market Cap	620.60 M
Div - Yield	0.00 - 0.00
Beta	1.05
PE (Forward)	21.67
Current Year Est.	0.84
Quarterly Earnings ESP	NA

PE (Forward)	21.67
PEG Ratio	1.30
Current Year Est.	0.84
Current Quarter Estimate	0.21
Most Accurate Estimate	NA
Earnings ESP	NA
Next Earnings Report Date	08-07-2013
EPS Last Year	0.61
Expected Earnings Growth	16.67%

Username: Password:

Remember me [?]

Omnicell Inc: (NASD: OMCL)

$18.25

0.05 (0.28%)

Volume 112,353

May 23 02:57 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description